A 74-year-old man with end-stage idiopathic pulmonary fibrosis is receiving home hospice care. He develops an acute, severe episode of dyspnea at rest, accompanied by marked distress and tachypnea. He is already receiving supplemental oxygen. Arrange the following palliative interventions for terminal dyspnea in the most appropriate stepwise order of escalation, from the initial measure (first) to the intervention of last resort (last).
- 1Maximize non-pharmacologic measures (e.g., directing a cool fan at the face, optimizing positioning)
- 2Administer a systemic opioid (e.g., low-dose sublingual morphine)
- 3Add a benzodiazepine (e.g., lorazepam) if anxiety secondary to dyspnea persists despite opioid therapy
- 4Initiate palliative sedation (e.g., continuous midazolam infusion) for refractory, intolerable symptoms
Answer
The correct sequence begins with non-pharmacologic measures, proceeds to systemic opioids, then adds benzodiazepines for refractory anxiety, and finally culminates in palliative sedation if symptoms become entirely intractable.
The proper stepwise management of terminal dyspnea begins with non-pharmacologic optimization, followed by systemic opioids as the primary pharmacologic agent. If symptoms or associated anxiety persist, benzodiazepines are added as an adjunct. Finally, if the dyspnea remains refractory and intolerable despite maximal therapy, palliative sedation is initiated as the treatment of last resort.
Step-by-Step Solution
Key Concept
The stepwise escalation of therapy for refractory dyspnea at the end of life prioritizes non-pharmacologic interventions and opioids, followed by benzodiazepines for anxiety, and palliative sedation strictly as a last resort.
Alternative Method
In some rapidly escalating scenarios (e.g., acute catastrophic hemorrhage or massive pulmonary embolism in a dying patient), steps may be compressed, and providers may move directly from opioids to sedation, but the general hierarchy of preference remains identical.
Estimated Time:1m 0s